# Two Biologics for Psoriatic Arthritis Square Off in Big Trial

Source: [MedPageToday.com - medical news for physicians](https://www.medpagetoday.com/meetingcoverage/acr/123825) · 2026-11-11 · Medicine
Page: https://themorning.science/story/two-biologics-for-psoriatic-arthritis-square-off-in-big-trial-b2831e6274f2926d
Kind: research · Impact: medium

## In brief

- A large head-to-head trial compared bimekizumab (Bimzelx) with risankizumab (Skyrizi) as treatments for psoriatic arthritis.
- The trial was reported at a meeting in Orlando and identified a winner, though with some caveats.

## Why it matters

Head-to-head comparisons of biologic treatments give clinicians direct evidence for choosing between options for psoriatic arthritis.

## Timeline

- 2026-11-11: Head-to-head trial of bimekizumab and risankizumab in psoriatic arthritis reported at the ACR meeting in Orlando

## Coverage

- [Two Biologics for Psoriatic Arthritis Square Off in Big Trial](https://www.medpagetoday.com/meetingcoverage/acr/123825) — MedPageToday.com - medical news for physicians, 2026-11-11

Tags: psoriatic arthritis, bimekizumab, risankizumab, head-to-head trial, biologics, rheumatology

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science